These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12212505)

  • 1. [Universal vaccination against group C meningococci and pneumococci; advice from the Health Council of the Netherlands].
    de Vries M; Dankert J; Ruijs H; Timen A; de Greeff S; de Melker H
    Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1562-3. PubMed ID: 12212505
    [No Abstract]   [Full Text] [Related]  

  • 2. [Universal vaccination against group-C meningococci and pneumococci; summary of the advice from the Health Counsil of the Netherlands].
    Ruitenberg EJ; Houweling H
    Ned Tijdschr Geneeskd; 2002 May; 146(20):938-40. PubMed ID: 12051061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Universal vaccination against group C meningococci and pneumococci; advice from the Health Council of the Netherlands].
    van Furth AM; Vandenbroucke-Grauls CM
    Ned Tijdschr Geneeskd; 2002 May; 146(20):932-3. PubMed ID: 12051059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acceptance of the new conjugate vaccines. Meningococcal and pneumococcal vaccines, in the cohort born in 1999, in the North Region of Portugal].
    De Queirós L; Castro L; Ferreira MC; Gonçalves G
    Acta Med Port; 2004; 17(1):49-53. PubMed ID: 15636727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survey on vaccination strategies used in different Italian Regions, for the 7-valent conjugate pneumococcal, meningococcal C and varicella vaccines].
    D'Ancona F; Alfonsi V; Ciofi degli Atti ML
    Ig Sanita Pubbl; 2006; 62(5):483-92. PubMed ID: 17206224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningococcus C vaccination programme.
    Murphy JF
    Ir Med J; 2000 Sep; 93(6):164. PubMed ID: 11105434
    [No Abstract]   [Full Text] [Related]  

  • 7. [Time to vaccinate infants and small children against pneumococci].
    Silfverdal SA; Gothefors L
    Lakartidningen; 2006 Feb 15-21; 103(7):477-8. PubMed ID: 16535879
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serious invasive pneumococcal disease in young children: the importance of vaccination].
    Haveman LM; Geelen SP; Sanders EA; Wolfs TF
    Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1917-20. PubMed ID: 12404904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making.
    Welte R; van den Dobbelsteen G; Bos JM; de Melker H; van Alphen L; Spanjaard L; Rümke HC; Postma MJ
    Vaccine; 2004 Dec; 23(4):470-9. PubMed ID: 15530695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sweden should follow Norway and introduce vaccination against pneumococci].
    Schulman S; Sveger T
    Lakartidningen; 2006 Feb 15-21; 103(7):480. PubMed ID: 16535881
    [No Abstract]   [Full Text] [Related]  

  • 11. Meningococcal group C disease in Greece during 1993-2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians.
    Kafetzis DA; Stamboulidis KN; Tzanakaki G; Kourea Kremastinou J; Skevaki CL; Konstantopoulos A; Tsolia M
    Clin Microbiol Infect; 2007 May; 13(5):550-2. PubMed ID: 17378929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal C conjugate vaccination recommendations for infants. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 Nov; 33(ACS-11):1-12. PubMed ID: 18064747
    [No Abstract]   [Full Text] [Related]  

  • 13. [Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk].
    de Greeff SC; Sanders EA; de Melker HE; van der Ende A; Vermeer PE; Schouls LM
    Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1454-7. PubMed ID: 17633974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The first effect of the national vaccination campaign against meningococcal-C disease: a rapid and sharp decrease in the number of patients].
    de Greeff SC; de Melker HE; Spanjaard L; van den Hof S; Dankert J
    Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1132-5. PubMed ID: 12822525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal B vaccine: new drug. The only vaccine against some serogroup B meningococci.
    Prescrire Int; 2008 Jun; 17(95):95-7. PubMed ID: 18623907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska.
    Moore MR; Hyde TB; Hennessy TW; Parks DJ; Reasonover AL; Harker-Jones M; Gove J; Bruden DL; Rudolph K; Parkinson A; Butler JC; Schuchat A
    J Infect Dis; 2004 Dec; 190(11):2031-8. PubMed ID: 15529269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of pneumococcal, meningococcal and Haemophilus influenzae type B infections in childhood].
    Schaad UB
    Ther Umsch; 1982 Sep; 39(9):717-25. PubMed ID: 7179181
    [No Abstract]   [Full Text] [Related]  

  • 18. [Public health management in invasive meningococcal diseases].
    Ehrhard I; Arndt U
    Gesundheitswesen; 2004 Dec; 66(12):790-5. PubMed ID: 15609213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mode of splenectomy and immunogenicity of meningococcal vaccination in patients with hereditary spherocytosis.
    Stoehr GA; Luecken J; Zielen S; Eber SW; Borrow R; Rose MA
    Br J Surg; 2008 Apr; 95(4):466-71. PubMed ID: 18161897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal vaccination: yes or no.
    Sharda KB
    Indian Pediatr; 2008 Jun; 45(6):519. PubMed ID: 18599950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.